Dr. Sah’s research is centered on improving outcomes in pediatric epilepsy, particularly in drug-resistant epilepsy, neonatal seizures, and epilepsy surgery. His work spans both single-center and multicenter studies, including collaborations through the Pediatric Epilepsy Research Consortium. His scholarly focus includes optimization of EEG metrics, identification of predictors of surgical outcomes, and evaluation of emerging therapies, including neurostimulation and novel antiseizure medications. He has contributed to peer-reviewed publications and national presentations, reflecting a sustained commitment to advancing evidence-based epilepsy care.